Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/32331

Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study


no-thumbnailVer/Abrir:

 Personality and psychiatric disorders in chronic pain male affected.pdf



826,36 kB
Adobe PDF
Compartir:

Este recurso está restringido

Título :
Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study
Autor :
Ajo Ferrer, Raquel  
Inda, Maria del Mar
Mateu, Margarita
Segura, Ana
Ballester, Purificación
Muriel, Javier  
Sellers, Rafael
Ferrández, Guillermina
Margarit, César
Peiró, Ana  
Editor :
Springer Nature
Departamento:
Departamentos de la UMH::Farmacología, Pediatría y Química Orgánica
Fecha de publicación:
2020-05
URI :
https://hdl.handle.net/11000/32331
Resumen :
The prevalence of personality disorders (PDs) and sexual dysfunction in chronic pain patients is higher than in general population. Our main objective was to analyse the influence of PD in patients with erectile dysfunction and chronic non-cancer pain and their response to andrological treatment. One-hundred one patients were included along 30 months. Pain intensity, quality of life, sexual life quality, anxiety and depression were analysed together with opioid dose. Erectile functioning was measured with the International Index of Erectile Function (IIEF) and PDs with Millon Clinical Multiaxial Inventory (MCMI-III). The mean age was 57 ± 12 years old, with moderate to severe pain, 70% were sexually active and presented moderate to severe ED. PDs were very frequent (31%, cut-off 85 and 84% cut-off 75 scores) mostly anxiety, compulsive, though disorder, somatoform and narcissistic. Self-defeating feature presence was significantly correlated (r = -0.4, 95% CI = -0.605 to -0.145, p = 0.002) with a more severe baseline ED and narcissistic, and a better response to andrological treatment (p = 0.010, d = 1.082). Patients with dysthymia features required significantly higher opioid doses vs. control (238 vs. 102 mg/day, respectively). These findings underline the importance of diagnosing PDs to rigorously treat patients with chronic pain and ED.
Área de conocimiento :
CDU: Ciencias aplicadas: Medicina: Farmacología. Terapéutica. Toxicología. Radiología
Tipo documento :
application/pdf
Derechos de acceso:
info:eu-repo/semantics/closedAccess
DOI :
https://doi.org/10.1038/s41443-020-0294-9
Aparece en las colecciones:
Artículos Farmacología, Pediatría y Química Orgánica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.